View Author
mutation protein prostate expression interaction tumor cancer patient receptor activity analysis idh 1 mutations promoter tissue androgen study binding idh 1 motif sequence tgase domain fxxlf glioma result function presence residue loss r 132h figure transglutaminase tp 53 mutations ar fxxlf motif ar lbd androgen receptor prostatic dubbink activation region tumours htg p coactivator clone factor astrocytoma prostate-specific table peptide odiii sample plasma wild-type n /c interaction prostate cancer lxxll experiment enzyme non-p.r 132h mutations tgm 4 promoter fragment tumour assay idh 2 mutations yeast chapter grade tgm 4 gene survival position colorectal status methylation chromosome mgmt promoter methylation response tp 53 mutation transcription gland ligand staining
10 Most Recent Publications
|
Identification of Familial Adenomatous Polyposis carriers among children with desmoid tumours
(Article)
Kattentidt-Mouravieva, A.A. Geurts-Giele, I.R.R. Wagner, A. Krijger, R.R. de Noesel, M.M. van Ven, C.P. van de Ouweland, A.M.W. van den Kromosoeto, J.N.R. Dinjens, W.N.M. Dubbink, H.J. Smits, R. |
2012-08-01
|
|
PTEN in colorectal cancer: A report on two Cowden syndrome patients
(Article)
Kersseboom, R. Dubbink, H.J. Morreau, H. Wagner, A. Corver, W.E. Tilburg, A.J.P. van Poley, J.W. Leerdam, M.E. van Atmodimedjo, P.N. Laar, I.M.B.H. van de Collee, J.M. Dinjens, W.N.M. |
2012-06-01
|
|
Donor-transmitted metastasis of colorectal carcinoma in a transplanted liver
(Article)
Zelinkova, Z. Geurts-Giele, I. Verheij, J. Metselaar, H.J. Dinjens, W.N.M. Dubbink, H.J. Taimr, P. |
2012-01-01
|
|
First-line temozolomide chemotherapy in progressive low-grade astrocytomas after radiotherapy: Molecular characteristics in relation to response
(Article)
Taal, W. Dubbink, H.J. Heuvel, I. van Holt, B. van der Bromberg, J.E.C. Smitt, P.A. Dinjens, W.N.M. Bent, M.J. van den Zonnenberg, B.A. Postma, T.J. Gijtenbeek, J. Boogerd, W. Groenendijk, F.H. Kros, J.M. Kouwenhoven, M.C.M. Marion, R. van |
2011-02-01
|
|
IDH1 and IDH2 mutations are prognostic but not predictive for outcome in anaplastic oligodendroglial tumors: A report of the European Organization for Research and Treatment of Cancer Brain Tumor Group
(Article)
Bent, M.J. van den Dubbink, H.J. Marion, R. van Kros, J.M. Dinjens, W.N.M. Gorlia, T. Sanson, M. Marie, Y. Brandes, A. Taphoorn, M.J. Wesseling, P. Frenay, M. Tijssen, C.C. Lacombe, D. Idbaih, A. |
2010-03-01
|
|
Segregation of non-p.R132H mutations in IDH1 in distinct molecular subtypes of glioma
(Article)
Gravendeel, A.M. Kloosterhof, N.K. Bent, M.J. van den Smitt, P.A. French, P.J. Bralten, L.B.C. Marion, R. van Dubbink, H.J. Dinjens, W.N.M. Bleeker, F.E. Hoogenraad, C.C. Michiels, E.M.C. Kros, J.M. |
2010-03-01
|
|
A review on the molecular diagnostics of Lynch syndrome: A central role for the pathology laboratory
(Article)
Lier, M.G.F. van Wagner, A. Leerdam, M.E. van Biermann, K. Kuipers, E.J. Steyerberg, E.W. Dubbink, H.J. Dinjens, W.N.M. |
2010-01-01
|
|
Isocitrate dehydrogenase-1 mutations: a fundamentally new understanding of diffuse glioma?
(Article)
Kloosterhof, N.K. Bralten, L.B.C. Dubbink, H.J. French, P.J. Bent, M.J. van den |
2010-01-01
|
|
MGMT promoter hypermethylation is a frequent, early, and consistent event in astrocytoma progression, and not correlated with TP53 mutation
(Article)
Groenendijk, F.H. Taal, W. Dubbink, H.J. Haarloo, C.R. Kouwenhoven, M.C.M. Bent, M.J. van den Kros, J.M. Dinjens, W.N.M. |
2010-01-01
|
|
Functional analysis of novel androgen receptor mutations in a unique cohort of Indonesian patients with a disorder of sex development
(Article)
Elfferich, P. Juniarto, A.Z. Drop, S.L.S. Faradz, S.M.H. Brüggenwirth, H.T. Brinkmann, A.O. Dubbink, H.J. Royen, M.E. van Molier, M. Hoogerbrugge, J.W. Houtsmuller, A.B. Trapman, J. Santosa, A. Jong, F.H. de |
2009-12-01
|
